Annual ROA
-73.45%
-41.25%-128.11%
31 December 2023
Summary:
XTL Biopharmaceuticals annual return on assets is currently -73.45%, with the most recent change of -41.25% (-128.11%) on 31 December 2023. During the last 3 years, it has fallen by -28.02% (-61.68%). XTLB annual ROA is now -120.30% below its all-time high of 361.82%, reached on 31 December 2009.XTLB ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-13.87%
+49.25%+78.03%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly return on assets is currently -13.87%, with the most recent change of +49.25% (+78.03%) on 31 March 2024. Over the past year, it has increased by +54.96% (+79.85%). XTLB quarterly ROA is now -108.92% below its all-time high of 155.53%, reached on 31 December 2009.XTLB Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -128.1% | +79.8% |
| 3 y3 years | -61.7% | +65.0% |
| 5 y5 years | -273.5% | -192.7% |
XTLB ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1218.0% | at low | -155.4% | +81.4% |
| 5 y | 5 years | -273.5% | at low | -155.4% | +81.4% |
| alltime | all time | -120.3% | +65.1% | -108.9% | +94.6% |
XTL Biopharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | -13.87%(-78.0%) |
| Dec 2023 | -73.45%(+128.1%) | -63.12%(-8.3%) |
| Sept 2023 | - | -68.83%(-7.8%) |
| June 2023 | - | -74.63%(+22.2%) |
| Mar 2023 | - | -61.07%(+143.1%) |
| Dec 2022 | -32.20%(-590.1%) | -25.12%(-200.4%) |
| Sept 2022 | - | 25.03%(+6.4%) |
| June 2022 | - | 23.53%(+142.6%) |
| Mar 2022 | - | 9.70%(+54.2%) |
| Dec 2021 | 6.57%(-114.5%) | 6.29%(-115.9%) |
| Sept 2021 | - | -39.61%(-1.5%) |
| June 2021 | - | -40.23%(+8.1%) |
| Mar 2021 | - | -37.22%(-4.5%) |
| Dec 2020 | -45.43%(+329.4%) | -38.97%(+30.1%) |
| Sept 2020 | - | -29.96%(-12.9%) |
| June 2020 | - | -34.40%(-37.7%) |
| Mar 2020 | - | -55.25%(+578.7%) |
| Dec 2019 | -10.58%(-125.0%) | -8.14%(-154.4%) |
| Sept 2019 | - | 14.97%(-62.0%) |
| June 2019 | - | 39.35%(-48.2%) |
| Mar 2019 | - | 75.95%(+51.2%) |
| Dec 2018 | 42.33%(-456.9%) | 50.23%(+74.5%) |
| Sept 2018 | - | 28.78%(-24.2%) |
| June 2018 | - | 37.95%(+139.3%) |
| Mar 2018 | - | 15.86%(-244.1%) |
| Dec 2017 | -11.86%(-85.9%) | -11.01%(-65.6%) |
| Sept 2017 | - | -31.99%(-54.3%) |
| June 2017 | - | -69.98%(+14.1%) |
| Mar 2017 | - | -61.33%(-2.6%) |
| Dec 2016 | -84.36%(+4.2%) | -62.96%(-21.5%) |
| Sept 2016 | - | -80.22%(+13.7%) |
| June 2016 | - | -70.53%(+17.6%) |
| Mar 2016 | - | -59.97%(-10.7%) |
| Dec 2015 | -80.99%(+59.6%) | -67.14%(+43.0%) |
| Sept 2015 | - | -46.95%(-5.2%) |
| June 2015 | - | -49.50%(-6.6%) |
| Mar 2015 | - | -52.99%(+26.2%) |
| Dec 2014 | -50.76%(+9.6%) | -41.98%(-24.9%) |
| Sept 2014 | - | -55.89%(+50.6%) |
| June 2014 | - | -37.12%(-6.8%) |
| Mar 2014 | - | -39.83%(+5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | -46.33%(+269.5%) | -37.75%(+128.2%) |
| Sept 2013 | - | -16.54%(-31.4%) |
| June 2013 | - | -24.10%(+13.5%) |
| Mar 2013 | - | -21.24%(+16.8%) |
| Dec 2012 | -12.54%(-57.7%) | -18.19%(-17.1%) |
| Sept 2012 | - | -21.94%(-25.4%) |
| June 2012 | - | -29.41%(+20.8%) |
| Mar 2012 | - | -24.35%(-10.9%) |
| Dec 2011 | -29.63%(-10.5%) | -27.32%(-2.5%) |
| Sept 2011 | - | -28.03%(-14.8%) |
| June 2011 | - | -32.89%(-25.7%) |
| Mar 2011 | - | -44.25%(-33.7%) |
| Dec 2010 | -33.11%(-109.2%) | -66.79%(-29.6%) |
| Sept 2010 | - | -94.82%(-36.6%) |
| June 2010 | - | -149.50%(-274.9%) |
| Mar 2010 | - | 85.47%(-45.0%) |
| Dec 2009 | 361.82%(-272.1%) | 155.53%(-160.4%) |
| Sept 2009 | - | -257.54%(+29.5%) |
| June 2009 | - | -198.85%(+10.2%) |
| Mar 2009 | - | -180.42%(-3.3%) |
| Dec 2008 | -210.25%(+72.9%) | -186.66%(+162.3%) |
| Sept 2008 | - | -71.16%(-34.1%) |
| June 2008 | - | -108.02%(-12.6%) |
| Mar 2008 | - | -123.63%(+7.7%) |
| Dec 2007 | -121.57%(+68.9%) | -114.77%(-6.4%) |
| Sept 2007 | - | -122.60%(+34.9%) |
| June 2007 | - | -90.85%(+46.6%) |
| Mar 2007 | - | -61.98%(+3.6%) |
| Dec 2006 | -71.97%(+4.7%) | -59.85%(-6.9%) |
| Sept 2006 | - | -64.32%(-9.6%) |
| June 2006 | - | -71.17%(-17.7%) |
| Mar 2006 | - | -86.46%(+24.9%) |
| Dec 2005 | -68.74%(+6.9%) | -69.21%(+16.0%) |
| Sept 2005 | - | -59.67%(-6.7%) |
| June 2005 | - | -63.94%(-14.9%) |
| Mar 2005 | - | -75.15%(-9.4%) |
| Dec 2004 | -64.29%(+11.8%) | -82.98%(+1.9%) |
| Sept 2004 | - | -81.47%(+45.0%) |
| June 2004 | - | -56.19% |
| Dec 2003 | -57.49%(+28.9%) | - |
| Dec 2002 | -44.61%(+94.0%) | - |
| Dec 2001 | -23.00% | - |
FAQ
- What is XTL Biopharmaceuticals annual return on assets?
- What is the all time high annual ROA for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual ROA year-on-year change?
- What is XTL Biopharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly ROA year-on-year change?
What is XTL Biopharmaceuticals annual return on assets?
The current annual ROA of XTLB is -73.45%
What is the all time high annual ROA for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual return on assets is 361.82%
What is XTL Biopharmaceuticals annual ROA year-on-year change?
Over the past year, XTLB annual return on assets has changed by -41.25% (-128.11%)
What is XTL Biopharmaceuticals quarterly return on assets?
The current quarterly ROA of XTLB is -13.87%
What is the all time high quarterly ROA for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly return on assets is 155.53%
What is XTL Biopharmaceuticals quarterly ROA year-on-year change?
Over the past year, XTLB quarterly return on assets has changed by +54.96% (+79.85%)